MORE►
AstraZeneca
Renibus Therapeutics CEO Jeff Keyser [Composite photo; original: Renibus Therapeutics]
BioNTX To Honor Renibus Therapeutics CEO with its 2024 Dennis K. Stone Award at iC³ Conference
by Lance Murray | Oct 2, 2024
Renibus CEO Jeff Keyser will be acknowledged as the award recipient at the 10th Annual iC³ Life Science & Healthcare Innovation Summit on Thursday, the first day of the Oct. 3-4 summit at the Loews Arlington Hotel & Convention Center.
by Quincy Preston |
Sep 1, 2023
Tarleton State University received the go-ahead for a new biotechnology institute as part of Texas A&M-Fort Worth’s burgeoning downtown research campus.
Approved in mid-August by the Texas A&M University System Board of Regents, the biotech institute is situated in one of the nation’s fastest-growing life sciences hubs....
MORE►
by Kevin Cummings |
Feb 16, 2022
Renibus Therapeutics, which focuses on treatments for acute and chronic kidney diseases, announced closing a $35 million Series A funding round. Its new CEO, Frank Stonebanks, says "Renibus has arrived at a critical inflection point in its commitment to transform the prevention and treatment of kidney diseases."
MORE►
by David Seeley |
Jan 27, 2022
Some insights: TikTok is the world's fastest-growing brand; tech is the most valuable industry at $1.3 trillion; retail continues to thrive with Walmart jumping up a spot; the pharma sector showed faster growth over the last two years than any other; and the U.S. and China continue to dominate.
We spoke with the managing director of the company's Dallas Americas HQ about his firm's Texas business and plans for U.S. growth.
MORE►
